B+
Bull case
25%
Probability
Target price
$135.00
Analysis reference price unavailable
Analysis 2026-09-09 · RankAlpha Sentiment Codex
HQY
HealthEquityANasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
55%
Probability
Target price
$119.00
Analysis reference price unavailable
Analysis 2026-09-09 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$80.00
Analysis reference price unavailable
Analysis 2026-09-09 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-09-09
Recent news sentiment (30D)
+0.7
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+93.6
Score
AI commentary
News tone is positive and concentrated around the Q2 earnings release, but coverage is sparse. Social, options, short-interest, employee, and post-print analyst-revision data are unavailable, limiting confidence.
RankAlpha Sentiment Codex - 2026-09-09
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-08-27eventQ2 FY2027 results and raised guidanceMedium impact
HealthEquity reported 8% revenue growth, 11% adjusted EBITDA growth, a 48% adjusted EBITDA margin, 14% HSA asset growth, and raised fiscal 2027 guidance [#8-K-2026-08-27] [#SEC-8K-2026-08-27].
2026-09-30catalystInsider selling overhangMedium impact
A director reported open-market sales totaling approximately $798,000 on August 25, 2026; this is a sentiment overhang but not evidence of deteriorating operations [#SEC-FORM4-2026-08-27].
2027-01-31catalystHSA account and asset compoundingHigh impact
Record HSA accounts of 10.7 million and HSA assets of $37.9 billion, together with improving profitability, support continued operating leverage if growth persists [#SEC-8K-2026-08-27].
Recommendation
N/A
No formal recommendation provided.
As of 2026-09-09 • Updated nightlySource: Internal modelMethodology